FHH.TO First Trust AlphaDEX U.S. Health Care Sector Index ETF
The First Trust AlphaDEX U.S. Health Care Sector Index ETF (the "Fund") aims to closely match the performance of the StrataQuant Health Care Index, after accounting for its operating expenses. The Fund's investment strategy primarily involves purchasing and holding the individual stocks (Constituent Securities) that make up this target Index, maintaining their respective weightings, or investing in other instruments designed to achieve similar performance. The StrataQuant Health Care Index itself is developed by applying the AlphaDEX methodology to the Russell 1000 Index, which encompasses large and mid-capitalization companies within the U.S. stock market. From the qualifying securities found within the Russell 1000, only those belonging to the Health Care Sector are ultimately chosen to form the constituents of the StrataQuant Health Care Index.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| FHH.TO | +6.9% | +8.3% | +26.5% | +26.2% | +16.6% | +6.8% |
| Equity average (793 funds) | +0.2% | -0.5% | +8.4% | +10.1% | +12.0% | +5.7% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$258K net.
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | ZBH Zimmer Biomet Holdings, Inc. | 2.70% |
| 2 | CNC Centene Corporation | 2.54% |
| 3 | UHID Universal Health Services, Inc. (Class B) | 2.52% |
| 4 | CI The Cigna Group | 2.48% |
| 5 | MEDP Medpace Holdings, Inc. | 2.38% |
| 6 | REGN Regeneron Pharmaceuticals, Inc. | 2.27% |
| 7 | GEHC GE HealthCare Technologies Inc. | 2.26% |
| 8 | GMED Globus Medical, Inc. (Class A) | 2.25% |
| 9 | SOLV Solventum Corporation | 2.25% |
| 10 | LLY Eli Lilly and Company | 2.21% |
| 11 | TEM Tempus AI, Inc. (Class A) | 2.17% |
| 12 | EXEL Exelixis, Inc. | 2.16% |
| 13 | ZTS Zoetis Inc. | 2.11% |
| 14 | DXCM DexCom, Inc. | 2.08% |
| 15 | HALO Halozyme Therapeutics, Inc. | 2.06% |
| 16 | THC Tenet Healthcare Corporation | 2.05% |
| 17 | 0Y6X.L Medtronic Plc | 2.01% |
| 18 | COO The Cooper Companies, Inc. | 1.99% |
| 19 | AMGN Amgen Inc. | 1.98% |
| 20 | UTHR United Therapeutics Corporation | 1.96% |
| 21 | GH Guardant Health, Inc. | 1.94% |
| 22 | JAZZ Jazz Pharmaceuticals Plc | 1.92% |
| 23 | BSX Boston Scientific Corporation | 1.85% |
| 24 | BMY Bristol-Myers Squibb Company | 1.80% |
| 25 | INCY Incyte Corporation | 1.80% |
| 26 | CAI Caris Life Sciences, Inc. | 1.78% |
| 27 | NTRA Natera, Inc. | 1.73% |
| 28 | NBIX Neurocrine Biosciences, Inc. | 1.53% |
| 29 | STE Steris Plc | 1.53% |
| 30 | LH Labcorp Holdings Inc. | 1.51% |
| 31 | VTRS Viatris Inc. | 1.48% |
| 32 | ALGN Align Technology, Inc. | 1.48% |
| 33 | HCA HCA Healthcare, Inc. | 1.48% |
| 34 | EHC Encompass Health Corporation | 1.46% |
| 35 | CORT Corcept Therapeutics Inc. | 1.44% |
| 36 | QGEN QIAGEN N.V. | 1.43% |
| 37 | ASND Ascendis Pharma A/S | 1.42% |
| 38 | ABBV AbbVie Inc. | 1.41% |
| 39 | DGX Quest Diagnostics Incorporated | 1.38% |
| 40 | ANTM Elevance Health Inc. | 1.38% |
| 41 | RMD.AX ResMed Inc. | 1.35% |
| 42 | DVA DaVita Inc. | 1.31% |
| 43 | RVMD Revolution Medicines, Inc. | 1.10% |
| 44 | BDX Becton, Dickinson and Company | 1.07% |
| 45 | BBIO BridgeBio Pharma, Inc. | 1.07% |
| 46 | DOCS Doximity, Inc. (Class A) | 1.04% |
| 47 | BIIB Biogen Inc. | 1.00% |
| 48 | ABT Abbott Laboratories | 0.98% |
| 49 | CHE Chemed Corporation | 0.97% |
| 50 | ENSG The Ensign Group, Inc. | 0.96% |
| 51 | NVST Envista Holdings Corporation | 0.96% |
| 52 | HSIC Henry Schein, Inc. | 0.95% |
| 53 | VRTX Vertex Pharmaceuticals Incorporated | 0.94% |
| 54 | PFE Pfizer Inc. | 0.93% |
| 55 | MDGL Madrigal Pharmaceuticals, Inc. | 0.77% |
| 56 | AXSM Axsome Therapeutics, Inc. | 0.73% |
| 57 | ARWR Arrowhead Pharmaceuticals, Inc. | 0.68% |
| 58 | IDXX IDEXX Laboratories, Inc. | 0.56% |
| 59 | MDLN Medline Inc. (Class A) | 0.51% |
| 60 | ELAN Elanco Animal Health Incorporated | 0.49% |
| 61 | HUM Humana Inc. | 0.49% |
| 62 | SYK Stryker Corporation | 0.48% |
| 63 | ISRG Intuitive Surgical, Inc. | 0.47% |
| 64 | WST West Pharmaceutical Services, Inc. | 0.47% |
| 65 | UNH UnitedHealth Group Incorporated | 0.46% |
| 66 | VEEV Veeva Systems Inc. (Class A) | 0.45% |
| 67 | DHR Danaher Corporation | 0.45% |
| 68 | TMO Thermo Fisher Scientific Inc. | 0.45% |
| 69 | INSM Insmed Incorporated | 0.44% |
| 70 | JNJ Johnson & Johnson | 0.44% |
| 71 | BIO Bio-Rad Laboratories, Inc. (Class A) | 0.43% |
| 72 | A Agilent Technologies, Inc. | 0.43% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Jun 30, 2026 | C$0.1200 |
| Mar 31, 2026 | C$0.1200 |
| Dec 31, 2025 | C$0.0200 |
| Sep 29, 2025 | C$0.0100 |
| Jun 30, 2025 | C$0.0100 |
| Mar 31, 2025 | C$0.0100 |
| Sep 27, 2024 | C$0.0300 |
| Jun 28, 2024 | C$0.0300 |
| Mar 27, 2024 | C$0.0300 |
| Dec 28, 2023 | C$0.0300 |
| Sep 28, 2023 | C$0.0550 |
| Dec 29, 2022 | C$0.0500 |
| Sep 28, 2022 | C$0.0900 |
| Jun 29, 2022 | C$0.0130 |
| Dec 30, 2021 | C$2.2774 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in FHH.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error